When did AngioDynamics report Q2 2025 earnings?

AngioDynamics (ANGO) reported Q2 2025 earnings on July 15, 2025 before market open.

What were AngioDynamics's Q2 2025 revenue and EPS?

AngioDynamics reported revenue of $80.2M and diluted EPS of $-0.03 for Q2 2025.

Revenue beat the consensus estimate of $74.3M by $5.9M. EPS beat the consensus estimate of $-0.13 by $0.10.

Compared to the same quarter a year prior, revenue grew 12.9% from $71.0M a year earlier and diluted EPS grew 50.0% from $-0.06.

You can read the 10-K periodic report (0001275187-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported July 15, 2025 · Before market open

Revenue estimate$74.3M

EPS estimate-$0.13

Jul 21, 2026 (In 4 weeks)

Revenue estimate$80.2M

EPS estimate-$0.11

Q2 2025$80.2MBeat by $5.9M

Q2 2025-$0.03Beat by $0.10

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did AngioDynamics report Q2 2025 earnings?: AngioDynamics (ANGO) reported Q2 2025 earnings on July 15, 2025 before market open.
What were AngioDynamics's Q2 2025 revenue and EPS?: AngioDynamics reported revenue of $80.2M and diluted EPS of $-0.03 for Q2 2025.
Did AngioDynamics beat estimates in Q2 2025?: Revenue beat the consensus estimate of $74.3M by $5.9M. EPS beat the consensus estimate of $-0.13 by $0.10.
How did AngioDynamics's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 12.9% from $71.0M a year earlier and diluted EPS grew 50.0% from $-0.06.
Where can I find AngioDynamics's Q2 2025 SEC filings?: You can read the 10-K periodic report (0001275187-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.